Drug Database
Back to search

United States· US:10702-163_518e35dd-90ee-6cca-e063-6294a90a840f

Methylphenidate

A methylphenidate product containing methylphenidate hydrochloride, registered in United States by KVK-Tech, Inc.. The same ATC class is registered in 18 of our 19 countries.

ATC N06BA04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMethylphenidateATCN06BA04REGISTER NO.US:10702-163_518e35dd…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methylphenidate hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methylphenidate is registered in 18 of 19 countries.

Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search methylphenidate products by name

Methylphenidate · ATC N06BA04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylphenidate costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.

  • United States: $0.56 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Methylphenidate · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.87
  • IT Italy$0.68
  • US United States$0.56 (acquisition cost)
  • FR France$0.56
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHYLPHENIDATE HYDROCHLORIDE
Manufacturer
KVK-Tech, Inc.
Country
United States (US)
ATC code
N06BA04
ATC class
Methylphenidate
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1070216350
    500 mL in 1 BOTTLE (10702-163-50)
  • ndc11
    10702-163-50

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

196 interactions on record for methylphenidate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methylphenidate against other medicinesHow interaction checks work

Methylphenidate · interactions on record

196 records

  • 12 severe
  • 45 moderate
  • 3 minor
  • 128 info

Most severe, free to view

  • ProcarbazineL01XB01severe
  • OzanimodL04AA38severe
  • OzanimodL04AE02severe
  • CocaineN01BC01severe

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N06BA04

Methylphenidate, as other registers publish it.

All methylphenidate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3f935fd-97a2-4b25-ad0a-7928a86a50ea
GET /v1/drugs/f3f935fd-97a2-4b25-ad0a-7928a86a50ea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "METHYLPHENIDATE HYDROCHLORIDE",
  "productndc": "10702-163",
  "dosage_form": "SOLUTION",
  "dea_schedule": "CII",
  "strength_unit": "mg/5mL",
  "application_number": "ANDA207485",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about methylphenidate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console